Angitia Biopharmaceuticals
Angitia Biopharmaceuticals is a clinical-stage biotech company developing treatments for musculoskeletal diseases. It has raised $406M in funding and employs 63 people.
The growth story
Angitia Biopharmaceuticals grew from 18 to 63 employees between 2022 and 2026, raising $406M along the way, most recently a Series D in February 2026.
About
Angitia Biopharmaceuticals develops therapeutics for serious musculoskeletal conditions, focusing on unmet medical needs. The company is in the clinical stage, meaning its drugs are being tested in humans but not yet approved for sale.
The company has raised $406M, a notable sum for a biotech firm of its size, with its Series D round closing in February 2026. Its team of 63 includes experienced professionals from major pharmaceutical companies like Amgen and Pfizer.
Founders and leadership
Angitia's largest function is Operations, with 6 employees. The company's leadership likely includes experienced professionals from the biotech and pharmaceutical industries, given the team's background.
The Angitia Biopharmaceuticals org chart
Luna (Muyu) Li (Chief Operating Officer, Co-founder) leads 43 mapped leaders with 7 direct reports. Click +N to expand a team; names link to the person’s public profile.
Departments, and which ones grew
Headcount by function: Healthcare Services 7 (0% YoY), Business Development 7 (+17% YoY), Research 7 (+17% YoY), Legal 6 (+20% YoY), Human Resources 5 (+25% YoY), Information Technology 4 (0% YoY).
Talent flow
Angitia's team draws heavily from Amgen, with 14 former employees, and Pfizer, with 4. Alumni have moved to roles at Vertex Pharmaceuticals and J.P. Morgan Asset Management, among others.
Most common previous employers of Angitia Biopharmaceuticals staff: Amgen (14), Pfizer (4), Atara Biotherapeutics (3), bluebird bio (3), IQVIA (3), FDA (2). Former Angitia Biopharmaceuticals employees most often moved to Anthony Pettigrew Associates (1), Atossa Therapeutics (1), J.P. Morgan Asset Management (1), Vertex Pharmaceuticals (1), Runway BioAdvisory (1), Dauphinée Clinical Consultants (1).
Alumni worth knowing
Web traffic
Traffic mix: 0% direct, 0% search, 0% social, 0% paid.
What this company is made of
Most common skills at Angitia Biopharmaceuticals: Biotechnology (25), Clinical Trials (23), Pharmaceutics (21), Clinical Development (19), Drug Development (19), Project Management (16), Good Manufacturing Practice (GMP) (16), Biopharmaceuticals (15).
Where the team actually sits
Angitia Biopharmaceuticals people are concentrated in California, United States (17), United States (5), Massachusetts, United States (4), Los Angeles Metropolitan Area (3).
Search footprint
Angitia Biopharmaceuticals attracts about 65 organic search visits a month, traffic worth roughly $0K a month if bought through ads. It gained 3 ranking keywords and lost 2 in the last period.
What employees say
- Compensation
- 4.00 / 5
- Career opportunities
- 3.00 / 5
- Senior management
- 3.00 / 5
- Work-life balance
- 3.00 / 5
Frequently asked
Angitia Biopharmaceuticals has 63 employees as of September 2026.
Angitia Biopharmaceuticals has raised $406M in total, most recently a Series D round in February 2026.
Angitia Biopharmaceuticals was founded in 2018 by Luna (Muyu) Li.
Luna (Muyu) Li (Chief Operating Officer, Co-founder) sits at the top of Angitia Biopharmaceuticals's reporting structure, with 7 direct reports.
The most common previous employers of current Angitia Biopharmaceuticals staff are Amgen (14 people), Pfizer (4 people), Atara Biotherapeutics (3 people).
Former Angitia Biopharmaceuticals employees most often move to Anthony Pettigrew Associates (1), Atossa Therapeutics (1), J.P. Morgan Asset Management (1).
Angitia Biopharmaceuticals attracts about 65 organic search visits a month, worth roughly $0K a month in equivalent ad spend.
The most common skills among Angitia Biopharmaceuticals staff are Biotechnology, Clinical Trials, Pharmaceutics, Clinical Development, Drug Development.
Angitia Biopharmaceuticals staff are concentrated in California, United States (17), United States (5), Massachusetts, United States (4).
Angitia Biopharmaceuticals has about 7 people in Healthcare Services, up 0% over the past year, as of September 2026.
Angitia Biopharmaceuticals has about 7 people in Business Development, up 17% over the past year, as of September 2026.
Computed from 49 current and 12 former Angitia Biopharmaceuticals profiles, as of September 2026. Source: Crustdata.
Build this for any company
Every number on this page came from the Crustdata API. Point the MCP at a company and get the same org chart, alumni list and talent flow in one prompt.